For this evaluation, because the CD271+ cells were heterogeneously located within each tumor, we used a grading system that classified each case as either “strong,” if it had more than 50% CD271+ cells in the entire tumor, or “moderate-to-weak,” if it had less than 50%. Here, NGFR is linked to neoplasm.